Company page
Xencor, Inc.
Xencor, Inc. is a public company traded on the American stock market under the ticker XNCR. The company has a market capitalization of approximately $1.3 billion. Xencor focuses on developing innovative monoclonal antibody therapies for the treatment of various diseases.
- Ticker
- XNCR:NASDAQ
- Asset type
- Stock
- Market cap
- $2.07B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD